Conference on 'Development of Commercial Health Insurance in the 14th Five-Year Plan Period’ was held

Conference on ‘Development of Commercial Health Insurance in the 14th Five-Year Plan Period’ was held by CDRF on March 18th, 2022.

LI Wei, Chairperson of the Committee of Population, Resources and Environment of the CPPCC, Chairman of CDRF, and HUANG Hong, Former Vice Chairman of China Banking and Insurance Regulatory Commission delivered opening speeches. FANG Jin, Secretary General of CDRF, and Kevin Haninger, Vice President of international Policy of the Pharmaceutical Research and Manufacturers of America (PhRMA) delivered speeches. QIU Yue, Director of Research Department of CDRF, introduced the main findings of related research topics, conference invited Sherry Glied, Dean of New York University Graduate School of Public Service, and Ashoke Bhattacharjya, Executive Director of Global Health Policy at Johnson & Johnson to make comments.

ZHENG Bingwen, Director of World Social Security Research Center, Chinese Academy of Social Sciences, LOU Hong, Dean of National Medical Insurance Research Institute of Capital Medical University, SONG Ruilin, Executive Chairman of China Pharmaceutical Innovation and Research Development Association (PhIRDA), SHANG Jingguo, Secretary General of Insurance Association of China, SUO Lingyan, Deputy Dean of School of Economics, Peking University and representatives of relevant government departments discussed topics related to ‘Development of Commercial Health Insurance in the 14th Five-Year Plan Period’. The meeting was chaired by YU Jiantuo, Deputy Secretary General of CDRF.

As an important part of China's multi-level medical security system, commercial health insurance and its synergy with basic medical insurance is of great significance to the improvement of multi-level medical security system and the construction of healthy China.